Inventor
EUI CHUL LEE
Inventor
KR
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07DHeterocyclic compounds20%
A61BDiagnosis7%
C07CAcyclic or carbocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
G06NComputing arrangements based on specific computational models7%
G10LSpeech analysis techniques or speech synthesis7%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data7%
PatentTitleYear
12,522,602Derivatives having 2,3-dihydro-1H-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same202612,338,237Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same202512,087,323Device and method for voice-based trauma screening using deep-learning202411,713,3083,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2026Patents assigned to YUHAN CORP (3)· patent assignee history
2023–2026Based in KR· patent location history
2024Patents assigned to EMOCOG CO LTD (1)· patent assignee history
2025–2026Patents assigned to GREEN CROSS CORP (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| YUHAN CORP | 3 | 2023–2026 |
| GREEN CROSS CORP | 2 | 2025–2026 |
| EMOCOG CO LTD | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 4 | 2023–2026 |